HOOKIPA Pharma Inc. - Common Stock (NQ:HOOK)

0.8403 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HOOKIPA Pharma Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

HOOKIPA Pharma to Report Third Quarter 2022 Financial Results and Corporate Updates on November 14, 2022

November 07, 2022

From HOOKIPA Pharma Inc.

Via GlobeNewswire

HOOKIPA to Participate in the Sidoti Micro-Cap Virtual Conference

November 02, 2022

From HOOKIPA Pharma Inc.

Via GlobeNewswire

10 Best Medical Stocks Under $5 ↗

October 29, 2022

The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...

Via Talk Markets

Short Volatility Alert: HOOKIPA Pharma Inc. ↗

October 21, 2022

On Thursday, shares of HOOKIPA Pharma Inc. (NASDAQ: HOOK) experienced volatile short activity. After the activity, the stock price went up +4.96% to $1.27. The overall sentiment for HOOK has been...

Via Benzinga

Recap: HOOKIPA Pharma Q2 Earnings ↗

August 11, 2022

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: HOOKIPA Pharma Q1 Earnings ↗

May 16, 2022

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers

October 20, 2022

HOOKIPA Pharma, Inc. (NASDAQ: HOOK) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

Via Spotlight Growth

Why Is Indonesia Energy (INDO) Stock Up Today? ↗

October 20, 2022

Indonesia Energy (INDO) stock is climbing higher on Thursday after the company announced the discovery of oil in one of its new wells.

Via InvestorPlace

Why Is Hookipa (HOOK) Stock Up 26% Today? ↗

October 20, 2022

Hookipa (HOOK) stock is rocketing higher on Thursday after reaching a strategic collaboration and license agreement with Roche (RHHBF).

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 20, 2022

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.

Via Benzinga

HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers

October 20, 2022

From HOOKIPA Pharma Inc.

Via GlobeNewswire

Hookipa Shares Jump On New Preclinical Data On Cancer Immunotherapies ↗

April 13, 2022

HOOKIPA Pharma Inc (NASDAQ: HOOK) has

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 29, 2022

Via Benzinga

HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study ↗

July 25, 2022

The U.S. Food and Drug Administration (FDA) has accepted HOOKIPA Pharma’s (NASDAQ: HOOK) Investigational New Drug (IND) application for HB-300, a novel arenaviral immunotherapy for the treatment of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 22, 2022

Via Benzinga

HOOKIPA Pharma's Return On Capital Employed Insights ↗

June 21, 2022

According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% increase in earnings, the company posted a loss of $17.97 million.

Via Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗

April 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

HOOKIPA Pharma: Q4 Earnings Insights ↗

March 24, 2022

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:00 AM. Here's what investors need to know about the...

Via Benzinga

The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More ↗

April 10, 2022

Biotech stocks managed to carve out modest gains for the week ending April 8, defying the broader market weakness. The defensive nature of the stocks make them appealing in times of risk aversion.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 04, 2022

Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. Trading volume for Cognition Therapeutics's stock...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 25, 2022

Via Benzinga

HOOKIPA Pharma's Return On Capital Employed Overview ↗

March 25, 2022

Benzinga Pro data, HOOKIPA Pharma (NASDAQ:HOOK) reported Q4 sales of $3.90 million. Earnings fell to a loss of $21.23 million, resulting in a 5.96% decrease from last quarter....

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 24, 2022

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...

Via Benzinga

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

HOOKIPA Pharma Earnings Preview ↗

March 23, 2022

HOOKIPA Pharma (NASDAQ:HOOK) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Earnings Scheduled For March 24, 2022 ↗

March 24, 2022

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

How To Attend HOOKIPA Pharma Q4 2021 Earnings Conference Call ↗

March 18, 2022

HOOKIPA Pharma (NASDAQ:HOOK) will host a conference call at 08:30 AM ET on March 24, 2022, to discuss Q4 2021 earnings results. How to Attend HOOKIPA Pharma (HOOK) Conference Call...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 03, 2022

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.